Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs no antiplatelet therapy in patients with drug-eluting stents undergoing non-cardiac surgery
NCT02797548Phase 4Completed
- Start
- Mar 2017
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 4, randomised, open-label trial of aspirin in coronary artery disease (CAD). Primary endpoint: Composite of all-cause death, stent thrombosis, myocardial infarction, and stroke at 30 days. Started Mar 2017; status: completed.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02797548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02797548.